{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:18:44Z","timestamp":1787768324880,"version":"build-2784847793"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001590","name":"Health Research Board","doi-asserted-by":"publisher","award":["ICAT-2022-001"],"award-info":[{"award-number":["ICAT-2022-001"]}],"id":[{"id":"10.13039\/501100001590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>\n                    Carbapenemase-producing Enterobacterales (CPE) are a critical antimicrobial resistance (AMR) threat globally. The Caribbean region, despite its high global connectivity, varied healthcare infrastructure and rising antimicrobial use, remains underrepresented in CPE surveillance data. Our study aims to map and characterise the existing literature on CPE in the Caribbean, including bacterial species, carbapenemase types, detection methods, and epidemiological trends. A scoping review was conducted in accordance with PRISMA-ScR guidelines. MEDLINE, EMBASE, Cochrane CENTRAL and Web of Science were searched to 1\n                    <jats:sup>st<\/jats:sup>\n                    July 2025 in addition to grey literature (policy documents, guidelines, websites). Studies were included if they reported carbapenemase production among Enterobacterales from human, animal, or environmental sources in Caribbean nations (defined geophysically). Non-Caribbean studies and non-Enterobacterales organisms were excluded. Fourteen studies published between 2008 and 2024 met inclusion criteria. Reports originated from six countries: Cuba, Puerto Rico, Jamaica, Guadeloupe, the Dominican Republic, and Cura\u00e7ao.\n                    <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                    was the most frequently reported species. The most common carbapenemase enzymes were KPC (including KPC-2 and KPC-8), NDM-1, NDM-5 and OXA-48. Co-production of NDM and KPC was documented. Detection was largely hospital-based, though community and environmental isolates were also identified. High levels of AMR were observed, with colistin often the only active agent. Surveillance gaps are evident across many populous Caribbean nations. CPE are established in multiple Caribbean countries, but surveillance remains irregular and limited. Addressing critical gaps in diagnostic capacity, reporting and molecular surveillance is essential to ensure the region\u2019s inclusion in the global AMR response.\n                  <\/jats:p>","DOI":"10.1371\/journal.pgph.0007176","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:28:30Z","timestamp":1787765310000},"page":"e0007176","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Caribbean under the radar? A scoping review of carbapenemase-producing Enterobacterales across the region"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1207-4352","authenticated-orcid":true,"given":"Saied","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansara","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev Peeyush","family":"Nagassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5153-5174","authenticated-orcid":true,"given":"Liam P.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidelma","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Fitzgerald-Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"issue":"8","key":"pgph.0007176.ref001","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/antibiotics11081082","article-title":"Antimicrobial resistance and its spread is a global threat","volume":"11","author":"MM Aljeldah","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"pgph.0007176.ref002","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/healthcare11131946","article-title":"Antimicrobial resistance: a growing serious threat for global public health","volume":"11","author":"MA Salam","year":"2023","journal-title":"Healthcare"},{"issue":"10459","key":"pgph.0007176.ref003","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","journal-title":"Lancet"},{"issue":"9","key":"pgph.0007176.ref004","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"LS Munoz-Price","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"pgph.0007176.ref005","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing \u03b2-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"H Yigit","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"12","key":"pgph.0007176.ref006","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India","volume":"53","author":"D Yong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"pgph.0007176.ref007","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"LK Logan","year":"2017","journal-title":"J Infect Dis"},{"issue":"7","key":"pgph.0007176.ref008","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/jac\/dks121","article-title":"OXA-48-like carbapenemases: the phantom menace","volume":"67","author":"L Poirel","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"pgph.0007176.ref009","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"D van Duin","year":"2017","journal-title":"Virulence"},{"key":"pgph.0007176.ref010","unstructured":"Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. 2017. https:\/\/www.who.int\/publications\/i\/item\/WHO-EMP-IAU-2017.12"},{"key":"pgph.0007176.ref011","unstructured":"Global Antimicrobial Resistance and Use Surveillance System (GLASS). Accessed 2025 July 22. https:\/\/www.who.int\/initiatives\/glass"},{"key":"pgph.0007176.ref012","unstructured":"Antimicrobial resistance surveillance in Europe 2022 - 2020 data. 2022. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-surveillance-europe-2022-2020-data"},{"issue":"3","key":"pgph.0007176.ref013","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/CMR.00125-13","article-title":"Escherichia coli ST131, an intriguing clonal group","volume":"27","author":"M-H Nicolas-Chanoine","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"pgph.0007176.ref014","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00337-18","article-title":"Escherichia coli sequence type 410 is causing new international high-risk clones","volume":"3","author":"L Roer","year":"2018","journal-title":"mSphere"},{"key":"pgph.0007176.ref015","unstructured":"CDC. Antimicrobial Resistance Laboratory Networks. 2024. Accessed 2025 July 27. https:\/\/www.cdc.gov\/antimicrobial-resistance-laboratory-networks\/php\/about\/index.html"},{"key":"pgph.0007176.ref016","unstructured":"Canada PHA of. Canadian Antimicrobial Resistance Surveillance System (CARSS) 2024. 2024. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/drugs-health-products\/canadian-antimicrobial-resistance-surveillance-system-2024-executive-summary.html"},{"key":"pgph.0007176.ref017","unstructured":"Australian Commission on Safety and Quality in Health Care. AURA 2023: Fifth Australian report on antimicrobial use and resistance in human health. 2023. https:\/\/www.safetyandquality.gov.au\/our-work\/antimicrobial-resistance\/antimicrobial-use-and-resistance-australia-aura\/aura-2023-fifth-australian-report-antimicrobial-use-and-resistance-human-health"},{"issue":"8","key":"pgph.0007176.ref018","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30093-8","article-title":"Clinical bacteriology in low-resource settings: today\u2019s solutions","volume":"18","author":"S Ombelet","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"10014","key":"pgph.0007176.ref019","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0140-6736(15)00547-4","article-title":"Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries","volume":"387","author":"M Mendelson","year":"2016","journal-title":"Lancet"},{"key":"pgph.0007176.ref020","unstructured":"Global antibiotic resistance surveillance report 2025. 2025. https:\/\/www.who.int\/publications\/i\/item\/9789240116337"},{"key":"pgph.0007176.ref021","unstructured":"AMR surveillance in low and middle-income.\u2009\u2009\u2026 Wellcome Open Research. Accessed 2025 July 27. https:\/\/wellcomeopenresearch.org\/articles\/2-92\/v1"},{"key":"pgph.0007176.ref022","unstructured":"Valuks S. Joint initiative launched to address antimicrobial resistance in the Caribbean. ICARS 2025. Accessed 2025 July 21. https:\/\/icars-global.org\/amr-in-the-caribbean\/"},{"key":"pgph.0007176.ref023","unstructured":"Antimicrobial Resistance in the Caribbean. Caribbean Medical Journal. 2022. Accessed 2025 July 21. https:\/\/www.caribbeanmedicaljournal.org\/2022\/03\/15\/antimicrobial-resistance-in-the-caribbean\/"},{"key":"pgph.0007176.ref024","unstructured":"Director-General\u2019s opening remarks at the UNGA High-level Meeting on AMR - Political Leadership and Action on Antimicrobial Resistance: The Road to the 2024 UNGA High-level Meeting on AMR. 2023. Accessed 2025 July 27. https:\/\/www.who.int\/director-general\/speeches\/detail\/director-general-s-opening-remarks-at-the-unga-high-level-meeting-on-amr-political-leadership-and-action-on-antimicrobial-resistance"},{"key":"pgph.0007176.ref025","article-title":"World leaders declare target of 10% reduction in superbug deaths by 2030","author":"Lay K, Correspondent G Health","year":"2024","journal-title":"The Guardian"},{"key":"pgph.0007176.ref026","article-title":"PM signs declaration calling for concrete action to tackle antimicrobial resistance","author":"B Today","year":"2024","journal-title":"Barbados Today"},{"key":"pgph.0007176.ref027","unstructured":"Mottley M. Barbados Prime Minister Mia Mottley Lays Global Issues Bare in a Stunning Speech at the UN. Global Voices. 2024. Accessed 2025 July 27. https:\/\/globalvoices.org\/2024\/09\/29\/barbados-prime-minister-mia-mottley-lays-global-issues-bare-in-a-stunning-speech-at-the-un\/"},{"issue":"7","key":"pgph.0007176.ref028","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"AC Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"pgph.0007176.ref029","unstructured":"Scoping. PRISMA Statement. Accessed 2025 July 21. https:\/\/www.prisma-statement.org\/scoping"},{"key":"pgph.0007176.ref030","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"MJ Page","year":"2021"},{"issue":"4","key":"pgph.0007176.ref031","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/nmi2.54","article-title":"Emergence of Klebsiella pneumoniae clinical isolates producing KPC-2 carbapenemase in Cuba","volume":"2","author":"D Qui\u00f1ones","year":"2014","journal-title":"New Microbes New Infect"},{"key":"pgph.0007176.ref032","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/antibiotics11040514","article-title":"Multicenter study of carbapenemase-producing enterobacterales in Havana, Cuba, 2016-2021","volume":"11","author":"H Yu","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"pgph.0007176.ref033","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3390\/antibiotics11070942","article-title":"A retrospective study of risk factors, mortality, and treatment outcomes for infections with carbapenemase-producing enterobacterales in a Tertiary Hospital in Havana, Cuba","volume":"11","author":"H Yu","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"pgph.0007176.ref034","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2047-2994-3-24","article-title":"The occurrence of Enterobacteriaceae producing KPC carbapenemases in a general hospital in Curacao","volume":"3","author":"S Erkens-Hulshof","year":"2014","journal-title":"Antimicrob Resist Infect Control"},{"key":"pgph.0007176.ref035","doi-asserted-by":"crossref","first-page":"519169","DOI":"10.3389\/fmicb.2020.519169","article-title":"Distribution of beta-lactamase producing gram-negative bacterial isolates in Isabela River of Santo Domingo, Dominican Republic","volume":"11","author":"VV Calder\u00f3n","year":"2021","journal-title":"Front Microbiol"},{"key":"pgph.0007176.ref036","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijid.2015.03.002","article-title":"First case of NDM-1 producing Klebsiella pneumoniae in Caribbean islands","volume":"34","author":"S Bastian","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"3","key":"pgph.0007176.ref037","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jgar.2015.04.004","article-title":"Emergence of OXA-48-producing Escherichia coli in the Caribbean islands","volume":"3","author":"S Breurec","year":"2015","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"pgph.0007176.ref038","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3855\/jidc.7094","article-title":"New Delhi metallo-\u03b2-lactamase in Jamaica","volume":"10","author":"C-A Thoms-Rodriguez","year":"2016","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"pgph.0007176.ref039","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03459-22","article-title":"New Delhi Metallo-Beta-Lactamase (NDM)-5 in Uropathogenic Klebsiella pneumoniae in a Tertiary Care Hospital in Jamaica","volume":"11","author":"S Stone","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"5","key":"pgph.0007176.ref040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1086\/651670","article-title":"Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant","volume":"31","author":"CJ Gregory","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"pgph.0007176.ref041","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1128\/AAC.01633-10","article-title":"Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico","volume":"55","author":"IE Robledo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"pgph.0007176.ref042","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/14787210.2017.1268918","article-title":"The epidemiology of carbapenemases in Latin America and the Caribbean","volume":"15","author":"K Escand\u00f3n-Vargas","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"pgph.0007176.ref043","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14787210.2020.1813023","article-title":"Update on the epidemiology of carbapenemases in Latin America and the Caribbean","volume":"19","author":"JC Garc\u00eda-Betancur","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"11","key":"pgph.0007176.ref044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2811.220415","article-title":"Increased detection of carbapenemase-producing enterobacterales bacteria in Latin America and the Caribbean during the COVID-19 pandemic","volume":"28","author":"GR Thomas","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"pgph.0007176.ref045","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3390\/antibiotics13121117","article-title":"Carbapenem-resistant enterobacteriaceae bacteremia in pediatric patients in Latin America and the Caribbean: a systematic review and meta-analysis","volume":"13","author":"S Ruvinsky","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"pgph.0007176.ref046","doi-asserted-by":"crossref","first-page":"127249","DOI":"10.1016\/j.micres.2022.127249","article-title":"Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy","volume":"266","author":"J Ma","year":"2023","journal-title":"Microbiol Res"},{"issue":"1","key":"pgph.0007176.ref047","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1186\/s12879-025-11115-x","article-title":"Carbapenem-resistant Enterobacterales bloodstream infections related to death in two Brazilian tertiary hospitals","volume":"25","author":"LG de Araujo","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"9","key":"pgph.0007176.ref048","doi-asserted-by":"crossref","first-page":"1900123","DOI":"10.2807\/1560-7917.ES.2019.24.9.1900123","article-title":"Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018","volume":"24","author":"A Brolund","year":"2019","journal-title":"Euro Surveill"},{"key":"pgph.0007176.ref049","first-page":"165","article-title":"Vital signs: carbapenem-resistant Enterobacteriaceae","volume":"62","author":"Centers for Disease Control and Prevention CDC","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pgph.0007176.ref050","doi-asserted-by":"crossref","first-page":"756782","DOI":"10.3389\/fcimb.2021.756782","article-title":"Bloodstream infections caused by Klebsiella pneumoniae Carbapenemase-Producing P. aeruginosa Sequence Type 463, Associated With High Mortality Rates in China: a retrospective cohort study","volume":"11","author":"H Hu","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"pgph.0007176.ref051","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"KK Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"pgph.0007176.ref052","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/cid\/cix893","article-title":"Carbapenemase-producing organisms: a global scourge","volume":"66","author":"RA Bonomo","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"pgph.0007176.ref053","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance","volume":"59","author":"JDD Pitout","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"pgph.0007176.ref054","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tim.2014.09.003","article-title":"Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding","volume":"22","author":"L Chen","year":"2014","journal-title":"Trends Microbiol"},{"issue":"12","key":"pgph.0007176.ref055","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.tim.2011.09.005","article-title":"The emerging NDM carbapenemases","volume":"19","author":"P Nordmann","year":"2011","journal-title":"Trends Microbiol"},{"issue":"5","key":"pgph.0007176.ref056","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/jac\/dkx488","article-title":"Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae","volume":"73","author":"M Rozwandowicz","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"pgph.0007176.ref057","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/antibiotics13121139","article-title":"National multicenter study on the prevalence of carbapenemase-producing enterobacteriaceae in the post-COVID-19 era in Argentina: the RECAPT-AR study","volume":"13","author":"M Echegorry","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"pgph.0007176.ref058","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00018-1","article-title":"Rapid evolution of pan-\u03b2-lactam resistance in Enterobacterales co-producing KPC and NDM: insights from global genomic analysis after the COVID-19 pandemic","volume":"5","author":"FP Sellera","year":"2024","journal-title":"Lancet Microbe"},{"key":"pgph.0007176.ref059","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s11427-025-3113-x","article-title":"Global spread and evolution of KPC-2 and NDM-1-producing Gram-negative bacteria","volume":"69","author":"M Cai","year":"2026","journal-title":"Sci China Life Sci"},{"key":"pgph.0007176.ref060","unstructured":"Pan American Health Organization. Latin American and Caribbean network for antimicrobial resistance surveillance - ReLAVRA. Accessed 2025 July 22. https:\/\/www.paho.org\/en\/topics\/antimicrobial-resistance\/latin-american-and-caribbean-network-antimicrobial-resistance"},{"key":"pgph.0007176.ref061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297921","article-title":"Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries","volume":"19","author":"S Ajulo","year":"2024","journal-title":"PLoS One"},{"key":"pgph.0007176.ref062","doi-asserted-by":"crossref","DOI":"10.26633\/RPSP.2020.131","article-title":"Antimicrobial resistance: time for action","volume":"44","author":"JB da Silva Jr","year":"2020","journal-title":"Rev Panam Salud Publica"},{"issue":"2","key":"pgph.0007176.ref063","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/microorganisms13020282","article-title":"Tackling Infectious Diseases in the Caribbean and South America: Epidemiological Insights, Antibiotic Resistance, Associated Infectious Diseases in Immunological Disorders, Global Infection Response, and Experimental Anti-Idiotypic Vaccine Candidates Against Microorganisms of Public Health Importance","volume":"13","author":"A Justiz-Vaillant","year":"2025","journal-title":"Microorganisms"},{"issue":"1","key":"pgph.0007176.ref064","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13031-021-00428-8","article-title":"Challenges and opportunities for infection prevention and control in hospitals in conflict-affected settings: a qualitative study","volume":"15","author":"H Lowe","year":"2021","journal-title":"Confl Health"},{"key":"pgph.0007176.ref065","doi-asserted-by":"crossref","DOI":"10.26633\/RPSP.2023.106","article-title":"READ-ing antimicrobial stewardship in the Caribbean: a tri-nation document review","volume":"47","author":"T Rocke","year":"2023","journal-title":"Rev Panam Salud Publica"},{"issue":"8","key":"pgph.0007176.ref066","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/antibiotics12081342","article-title":"Antimicrobial Stewardship Programs in Latin America and the Caribbean: a story of perseverance, challenges, and goals","volume":"12","author":"N Restrepo-Arbel\u00e1ez","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"pgph.0007176.ref067","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/antibiotics12071094","article-title":"Knowledge, attitudes, and practices in antibiotic dispensing amongst pharmacists in Trinidad and Tobago: exploring a novel dichotomy of antibiotic laws","volume":"12","author":"RP Nagassar","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"pgph.0007176.ref068","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/antibiotics12030466","article-title":"Antimicrobial consumption from 2017 to 2021 in East Trinidad and Tobago: a study in the English-Speaking Caribbean","volume":"12","author":"RP Nagassar","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"pgph.0007176.ref069","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1472-8206.2009.00713.x","article-title":"Prescribing patterns and utilization of antimicrobial drugs in a tertiary care teaching hospital of a Caribbean developing country","volume":"23","author":"S Hariharan","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"pgph.0007176.ref070","unstructured":"CARPHA. State of public health. Accessed 2026 March 17. https:\/\/carpha.org\/What-We-Do\/Health-Information\/State-of-Public-Health"},{"key":"pgph.0007176.ref071","unstructured":"Antimicrobial consumption in the EU\/EEA (ESAC-Net) - Annual Epidemiological Report 2024. 2025. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-consumption-eueea-esac-net-annual-epidemiological-report-2024"},{"issue":"1","key":"pgph.0007176.ref072","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13756-023-01245-9","article-title":"Qualitative assessment of the national initiative to implement antimicrobial stewardship centres in French administrative regions","volume":"12","author":"M Conlin","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"issue":"9","key":"pgph.0007176.ref073","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(11)70054-8","article-title":"Non-prescription antimicrobial use worldwide: a systematic review","volume":"11","author":"DJ Morgan","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"pgph.0007176.ref074","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance-the need for global solutions","volume":"13","author":"R Laxminarayan","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"pgph.0007176.ref075","unstructured":"Pan American Health Organization. Tackling Antimicrobial Resistance in the Caribbean - PAHO\/WHO. 2025. Accessed 2025 August 27. https:\/\/www.paho.org\/en\/tackling-antimicrobial-resistance-caribbean"},{"key":"pgph.0007176.ref076","unstructured":"Fleming fund projects launched with CARPHA, UKHSA and PAHO to fortify the Caribbean\u2019s fight against antimicrobial resistance. PAHO\/WHO | Pan American Health Organization. 2025. Accessed 2025 August 27. https:\/\/www.paho.org\/en\/news\/6-5-2025-fleming-fund-projects-launched-carpha-ukhsa-and-paho-fortify-caribbeans-fight-against"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0007176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:28:42Z","timestamp":1787765322000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0007176"}},"subtitle":[],"editor":[{"given":"Sumanth","family":"Gandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":76,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0007176","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}